Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000902664-25-003728
Filing Date
2025-08-15
Accepted
2025-08-15 16:10:23
Documents
1
Period of Report
2025-08-07

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 4355
  Complete submission text file 0000902664-25-003728.txt   6419
Mailing Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072
Business Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 781-713-3699
COLLEGIUM PHARMACEUTICAL, INC (Issuer) CIK: 0001267565 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 155 EAST 44TH ST, SUITE 1630 NEW YORK NY 10017
Business Address 155 EAST 44TH ST, SUITE 1630 NEW YORK NY 10017 2124181881
Rubric Capital Management LP (Reporting) CIK: 0001687509 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37372 | Film No.: 251224702

Mailing Address 155 EAST 44TH ST., SUITE 1630 NEW YORK NY 10017
Business Address
Rosen David Efraim (Reporting) CIK: 0001898677 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37372 | Film No.: 251224701